Company Filing History:
Years Active: 2017-2023
Title: Innovations by Jürgen Schonhardt in Bone Treatment Technologies
Introduction
Jürgen Schonhardt is a notable inventor based in Rheinfelden, Germany. He has made significant contributions to the field of medical technology, particularly in the area of bone treatment. With a total of four patents to his name, Schonhardt's work focuses on innovative solutions for surgical applications.
Latest Patents
Among his latest patents are advancements in bone plates, surgical sets, and reconstruction sets. One of his key inventions is a bone plate designed for reconstruction or trauma treatment of a bone. This bone plate features first and second ends, along with a first contact surface that secures to a specific region of the bone. It includes multiple receiving mechanisms, each equipped with at least one opening for securing elements. Additionally, the design incorporates at least two adjacent wings extending from the first end of the main section, each with a second contact surface for securing to another region of the bone. The innovative design ensures that the minimum bending stiffness of the main section is greater than that of the wings, yet smaller than the total minimum bending stiffness of all wings extending from the first end.
Career Highlights
Jürgen Schonhardt has worked with prominent companies in the medical field, including Medartis Holding AG and Medartis AG. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in surgical technology.
Collaborations
Some of his notable coworkers include Hermann Zeuner and Andreas Mullis. Their collaboration has likely played a role in the development of his patented technologies.
Conclusion
Jürgen Schonhardt's contributions to medical technology, particularly in bone treatment, highlight his innovative spirit and dedication to improving surgical outcomes. His patents reflect a commitment to advancing healthcare solutions through engineering and design.